Status:
COMPLETED
Prevalence of Musculoskeletal Pain and Its Impact on Quality of Life and Functional Exercise Capacity in Patients With Pulmonary Arterial Hypertension
Lead Sponsor:
Izmir Bakircay University
Collaborating Sponsors:
Istanbul University - Cerrahpasa
Conditions:
Pulmonary Arterial Hypertension
Eligibility:
All Genders
18-99 years
Brief Summary
Prevalence of musculoskeletal pain and its impact of quality of life and functional exercise capacity will be evaluated in patients with pulmonary arterial hypertension.
Detailed Description
Although main symptoms of pulmonary arterial hypertension (PAH) include shortness of breath and exercise intolerance, patients may also experience symptoms related to musculoskeletal system such as mu...
Eligibility Criteria
Inclusion
- Diagnosis of pulmonary arterial hypertension
Exclusion
- Diagnosis of heart failure or any chronic respiratory disease
- Recent coronary bypass surgery
- Recent acute myocardial infarction
- Having a pacemaker
- Having any orthopedic or neurologic diseases which may impede walking or exercising
Key Trial Info
Start Date :
March 25 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 15 2021
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT04808830
Start Date
March 25 2021
End Date
June 15 2021
Last Update
June 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul University-Cerrahpasa, Institute of Cardiology
Istanbul, Turkey (Türkiye)